Philip Kantoff, MD, has been named the new chairman of the department of medicine at Memorial Sloan Kettering Cancer Center in New York City.
Here are six things to know about Dr. Kantoff.
1. In this role, Dr. Kantoff will continue to see patients, as well as head a program of laboratory-based research.
2. He has served in numerous capacities at the Dana-Farber Cancer Institute and Harvard Medical School in Boston since 1987.
3. Previously, Dr. Kantoff was director of the Lank Center for Genitourinary Oncology, chief of the division of solid tumor oncology, vice chairman of the department of medical oncology and chairman of the executive committee on clinical research at Dana-Farber, as well as a professor of medicine at HMS.
4. He also was the Jerome and Nancy Kohlberg Endowed Chair at HMS, leader of the Dana-Farber/Harvard Cancer Center Prostate Cancer Program, and director of its Prostate Cancer Specialized Program of Research.
5. Dr. Kantoff currently is chairman of the Global Treatment Science Network of the Prostate Cancer Foundation.
6. He succeeds George Bosl, MD, who steps down from his role after 18 years.
More articles on healthcare executive moves:
Proteus Digital Health names new board chairman, chief commercial officer: 11 things to know
Fuji names COO, CMO: 11 things to know
Presence selects Dana Gilbert as chief strategy and population health officer: 3 things to know